Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You sure that wasn't an etch a sketch.
Leo's building share holder value. Just going to take another six months to appreciate it. Leo strikes again.
So possibly we haven't yet hit the half way point.
What's got me curious though is no completion update. In the P2a trial we had an update at the half way point. Would a CDA call for this.
I don't believe there's a delay. Just a realization.
I'm concerned that between now and June share price is going to drift lower. I don't like this shooting from the hip PR drama and neither does the market. It's clear now that it's going to take a partners equity to change the course. Hopefully a deal is on deck.
My take is no 6 week, we will get the full 12 week next quarter. The term 6 week interim has not been used since Leo first outlined the protocols.
They are spreading their concerns of LPC financing. If I was that crew I'd be more concerned of all those insiders over there bailing.
I as many others here firmly believe P will be more great news. June can't get here soon enough.
P sure is quiet. It's all about the B now.
Norchi has gone radio silent. All we need now is for the ambulance chasers to show up. geez
News at 11..
When bulls take control bears retreat back in their holes. Time for a running of the bulls.
Yes your right .6m from Retts Organization. I thought I remembered the grant from Fox foundation as .6 also. Thanks.
http://www.anavex.com/anavex-awarded-grant-from-the-michael-j-fox-foundation-for-parkinsons-research/
MJFF promised 600k to fund Parkinsons Trial.
This was just a CC. The next PR should answer material questions.
12 week release by July so yes 6 week any day now.
I gathered we have funding and will soon be in three trials, not sure what you gathered.
Prurisol update anytime now.
"Only one Phase III trial may be required, enrolling fewer patients than is typical".
"Unsurprisingly, an increasing number of pharmaceutical companies are choosing this development approach, saving substantial time and money by leveraging existing research and data"
I believe Leo just told us it's all good. Prurisol 505(b)(2) on to market we go.
This does not equal a trial failure by any means, mistakes will be corrected and sp will again rise. Device is a proven winner.
Couldn't be anymore disappointed in managements handling of this valuable product. MIT may want their AC5 back.
Getting ready to spike so I may set one for $10 thanks.
I guess they're speaking from their own experience.
This quickly arranged conference call to me is a bullish indication of news we haven't heard yet. P would be a great call.
So you don't own and your cohorts recommend not buying. Yet you watch this stock like a hawk. Your so torn.
That is material information, but we know through company dialog there is more then one interest due to the fact they have more then one CDA. But does it really matter which companies.
Still got your stop loss set at 2 bucks. lol
Yes we do have catalysts between any day and the next few months but were now so far of the beaten path that a partnership announcement may take a week for news to get out.
There would be a whole lot more shares traded if we had the buyers. Leo is trying to make that happen.
I see it's smear campaign Wednesday.
So corporate achievements scare some investors.. hmmm
Very possible to have a P update. Leo plans to "discuss accomplishments to date and pipeline development going forward. More details will follow early next week".
Thanks, this positive MS study is great news. Shorts take that.
Agree. Leo's going for deep penetration..
Since the proposed CC is just next week tells me it will be live. Leo's put this together in hurry for a reason, think about that.
I would say that was a good business plan. After seeing positive results that the drug was working they added many more sites including the UP trial. No use throwing good money after bad.
What you posted were not opposing views. Yes this little OTC has a depressed stock price for now but not for the reasons you describe. The company is progressing nicely with it's trials. Bio takes time and much patience.
FDA granted Fast Track Designation for Brilacidin-OM. So far so good, Ctix will just need to meet back with FDA for approval I hope.
Due to the many AE side effects of bryostatin, I would say no problem for AVXL.